Efficacy and safety of TNF inhibitors in seronegative rheumatoid arthritis patients who are inadequate responders to csDMARDs. A systematic literature review with meta-analysis.
What are the benefit and harms of tumor necrosis factor inhibitors in seronegative rheumatoid arthritis patients who are inadequate responders to conventional synthetic DMARDs?
